In: Biotechnology

One Giant Leap Too Far, Why CRISPR is in the News

The title reads: “Easy DNA Editing Will Remake the World. Buckle Up.” From the outset this article in July’s Wired magazine…

Read More
Rare Diseases: The Role of Social Media in Patient Recruitment

Since the passing of the Orphan Drug Act in 1983, the rate of drug development in the United States has seen…

Read More
Want More Cures? Modernize Clinical Trials

As the federal government creates a plan to speed the pace of drug development in the U.S., one specialty contract research…

Read More
Lab Tools and Ancient Sea Life: Medicine’s Lust for a Crab’s Blood

In the pharmaceutical and biomedical industries, the horseshoe crab is nothing short of a celebrity. If you haven’t heard about this…

Read More
2014 FDA Drug Approvals at 18-year High, but How Much New Ground Are We Breaking?

As the New Year bells chimed in 2015, the curtains drew shut on this century’s best year for novel-drug approvals. The…

Read More
What You Cared About in 2014

As the year closes, one can’t help but reflect. So, we take a look back at our most popular blog posts…

Read More
The J.P. Morgan Healthcare Conference: Worth the Fuss?

Attendance is by invitation only. There’s no trade show floor. And, good luck tracking down information on speakers and schedules if…

Read More
Usability: Making Better Websites with Dead Simple User Experience

Let’s get something straight: We’re all marketing to humans. Yes, customers’ perspectives, experiences and industries may differ — even within the…

Read More
Top 10 Biotech IPOs of 2014: West Coast Dominates

What was the most successful biotech IPO of 2014? Look no further than Ultragenyx. A special report by Fierce Biotech says…

Read More
Replacing Adderall: Medicines to Change the World (Part I)

It’s a sad beginning to my series on medications set to change society and the way we live our lives. Shares…

Read More